单克隆丙种球蛋白病相关的血栓性微血管病
该回顾性研究纳入146例临床诊断血栓性微血管病(TMA)的成人患者,检出单克隆免疫球蛋白者20例(13.7%),50岁及以上人群患病率为21%,约为该人群预期4.2%的五倍;肾活检15例均见肾小球毛细血管壁双轨征,10例进展至终末期肾病。
要点
- TMA患者中单克隆丙种球蛋白病检出率为13.7%(20/146)。
- 50岁及以上TMA患者单克隆丙种球蛋白病患病率为21%,约为预期4.2%的五倍。
- 肾活检15例均见肾小球毛细血管壁双轨征,11例见系膜溶解。
核心结论
- TMA患者中单克隆丙种球蛋白病患病率出乎意料地高,提示其可能是TMA的潜在发病机制。
- 本研究强调应对TMA患者评估单克隆丙种球蛋白病,并提示针对潜在血液系统疾病可能成为治疗TMA的途径。
研究设计与样本
- 回顾性研究,纳入临床诊断为TMA的成人(18岁及以上)患者146例。
主要发现
- 146例TMA患者中检出单克隆免疫球蛋白20例(13.7%)。
- 50岁及以上患者中单克隆丙种球蛋白病患病率为21%,约为该人群预期4.2%的五倍。
- 20例中15例为意义未明单克隆丙种球蛋白病,1例多发性骨髓瘤,1例冒烟型骨髓瘤,2例POEMS综合征,1例T细胞淋巴细胞白血病。
- 肾活检15例中6例见血栓,11例见系膜溶解,全部见肾小球毛细血管壁双轨征,12例见急性肾小管损伤。
- 治疗选择多样,包括11例接受治疗性血浆置换;10例进展至终末期肾病,其中2例接受肾移植。
临床怎么用
- 作者认为应对TMA患者评估单克隆丙种球蛋白病,并提示针对潜在血液系统疾病可能成为治疗TMA的途径。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thrombotic microangiopathy (TMA) is a rare disease comprising of a diverse set of disorders linked by a common histologic finding of endothelial injury. Monoclonal immunoglobulins may act as a potential trigger in the pathogenesis of TMA. To determine the prevalence of monoclonal gammopathy and clinicopathological features of TMA associated with monoclonal immunoglobulin, we performed a retrospective study in adults (18 and older) with a clinical diagnosis of TMA. Of 146 patients with TMA, we detected monoclonal immunoglobulin in 20 patients (13.7%). Among patients 50 and older, the prevalence of monoclonal gammopathy was 21%, which is approximately five-fold higher than the 4.2% expected rate in this population. Fifteen patients had monoclonal gammopathy of undetermined significance, one had multiple myeloma, one with smoldering myeloma, two had POEMS syndrome, and one had T-cell lymphocytic leukemia. Renal biopsy was performed in 15 cases, of which six showed thrombi, 11 showed mesangiolysis, and all showed double contours along glomerular capillary walls. Acute tubular injury was present in 12 cases. Treatment options were varied and included therapeutic plasma exchange in 11 patients. Ten patients progressed to end-stage renal disease, of which two received kidney transplant. Thus, our study shows an unexpectedly high prevalence of monoclonal gammopathy in patients with TMA, suggesting a potential pathogenetic mechanism. This study underscores the importance of evaluating for a monoclonal gammopathy in patients with TMA as well as the potential for targeting the underlying hematologic disorder as an approach to treating TMA.
引用
- Ravindran A, Go RS, Fervenza FC, et al. Thrombotic microangiopathy associated with monoclonal gammopathy. Kidney Int. 2016. PMID: 27998645. doi:10.1016/j.kint.2016.09.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。